Cargando…

Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers

BACKGROUND: Evidence is accumulating that a cannabis withdrawal syndrome is common, of clinical significance, and has a clear time course. Up till now, very limited data exist on the cannabis withdrawal symptoms in patients with co-morbid substance use disorders, other than cannabis use and tobacco...

Descripción completa

Detalles Bibliográficos
Autores principales: Hesse, Morten, Thylstrup, Birgitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015312/
https://www.ncbi.nlm.nih.gov/pubmed/24118963
http://dx.doi.org/10.1186/1471-244X-13-258
_version_ 1782315317594161152
author Hesse, Morten
Thylstrup, Birgitte
author_facet Hesse, Morten
Thylstrup, Birgitte
author_sort Hesse, Morten
collection PubMed
description BACKGROUND: Evidence is accumulating that a cannabis withdrawal syndrome is common, of clinical significance, and has a clear time course. Up till now, very limited data exist on the cannabis withdrawal symptoms in patients with co-morbid substance use disorders, other than cannabis use and tobacco use. METHODS: Symptoms of withdrawal were assessed through patient self-reports during detoxification in Danish residential rehabilitation centers. Patients (n = 90) completed booklets three times during their first month at the treatment centre. Self-reported withdrawal symptoms was rated using the DSM-5 Withdrawal Symptom Check List with withdrawal symptoms from all classes of substances, with no indication that the described symptoms should be attributed to withdrawal. Self-reported time since last use of cannabis was used as a predictor of cannabis withdrawal severity. RESULTS: With the exception of loss of appetite, time since last use of cannabis was associated with all types of withdrawal symptoms listed in the DSM-5. Only four of 19 symptoms intended to measure withdrawal from other substances were related to time since last use of cannabis, including vivid, unpleasant dreams. CONCLUSIONS: The findings yield strong support to the notion of a cannabis withdrawal syndrome, and gives further evidence for the inclusion of the criterion of vivid, unpleasant dreams. Further, the findings speak against the significance of demand characteristics in determining the course of the symptoms of cannabis withdrawal.
format Online
Article
Text
id pubmed-4015312
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40153122014-05-10 Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers Hesse, Morten Thylstrup, Birgitte BMC Psychiatry Research Article BACKGROUND: Evidence is accumulating that a cannabis withdrawal syndrome is common, of clinical significance, and has a clear time course. Up till now, very limited data exist on the cannabis withdrawal symptoms in patients with co-morbid substance use disorders, other than cannabis use and tobacco use. METHODS: Symptoms of withdrawal were assessed through patient self-reports during detoxification in Danish residential rehabilitation centers. Patients (n = 90) completed booklets three times during their first month at the treatment centre. Self-reported withdrawal symptoms was rated using the DSM-5 Withdrawal Symptom Check List with withdrawal symptoms from all classes of substances, with no indication that the described symptoms should be attributed to withdrawal. Self-reported time since last use of cannabis was used as a predictor of cannabis withdrawal severity. RESULTS: With the exception of loss of appetite, time since last use of cannabis was associated with all types of withdrawal symptoms listed in the DSM-5. Only four of 19 symptoms intended to measure withdrawal from other substances were related to time since last use of cannabis, including vivid, unpleasant dreams. CONCLUSIONS: The findings yield strong support to the notion of a cannabis withdrawal syndrome, and gives further evidence for the inclusion of the criterion of vivid, unpleasant dreams. Further, the findings speak against the significance of demand characteristics in determining the course of the symptoms of cannabis withdrawal. BioMed Central 2013-10-12 /pmc/articles/PMC4015312/ /pubmed/24118963 http://dx.doi.org/10.1186/1471-244X-13-258 Text en Copyright © 2013 Hesse and Thylstrup; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hesse, Morten
Thylstrup, Birgitte
Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers
title Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers
title_full Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers
title_fullStr Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers
title_full_unstemmed Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers
title_short Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers
title_sort time-course of the dsm-5 cannabis withdrawal symptoms in poly-substance abusers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015312/
https://www.ncbi.nlm.nih.gov/pubmed/24118963
http://dx.doi.org/10.1186/1471-244X-13-258
work_keys_str_mv AT hessemorten timecourseofthedsm5cannabiswithdrawalsymptomsinpolysubstanceabusers
AT thylstrupbirgitte timecourseofthedsm5cannabiswithdrawalsymptomsinpolysubstanceabusers